Inventor
MANDLER MARKUS
AT12 patents
⚠️ This page may combine multiple inventors who share the name “MANDLER MARKUS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AFFIRIS AG
5 patentsUS10517935B2Dec 31, 2019
Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders
AFFIRIS AG1 citations67
US11065273B2Jul 20, 2021
Treatment and prevention of alzheimer's disease (AD)
AFFIRIS AG1 citations61
US10646565B2May 12, 2020
Treatment of alzheimer'S disease (AD) with an aluminum salt
AFFIRIS AG1 citations61
US10478454B2Nov 19, 2019
Treatment of Alzheimer's disease (AD) with aluminum oxyhydroxide
AFFIRIS AG0 citations51
US9964547B2May 8, 2018
Method for detecting aSyn-specific antibodies in a biological sample
AFFIRIS AG0 citations48
MANDLER MARKUS
4 patentsUS8613931B2Dec 24, 2013
Compounds for treating beta-amyloidoses
MANDLER MARKUS8 citations76
US9724399B2Aug 8, 2017
Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders
MANDLER MARKUS3 citations66
US8409581B2Apr 2, 2013
Compounds for treating amyloidoses
MANDLER MARKUS1 citations45
US8828942B2Sep 9, 2014
Means for treating synucleinopathies
MANDLER MARKUS0 citations31